These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18042830)

  • 21. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
    Donnelly-Roberts DL; Jarvis MF
    Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P2X receptor ligands and pain.
    Shieh CC; Jarvis MF; Lee CH; Perner RJ
    Expert Opin Ther Pat; 2006 Aug; 16(8):1113-27. PubMed ID: 20144056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.
    Perez-Medrano A; Donnelly-Roberts DL; Honore P; Hsieh GC; Namovic MT; Peddi S; Shuai Q; Wang Y; Faltynek CR; Jarvis MF; Carroll WA
    J Med Chem; 2009 May; 52(10):3366-76. PubMed ID: 19397270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain.
    Jarvis MF
    Expert Opin Ther Targets; 2003 Aug; 7(4):513-22. PubMed ID: 12885270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.
    Honore P; Kage K; Mikusa J; Watt AT; Johnston JF; Wyatt JR; Faltynek CR; Jarvis MF; Lynch K
    Pain; 2002 Sep; 99(1-2):11-9. PubMed ID: 12237180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purines and sensory nerves.
    Burnstock G
    Handb Exp Pharmacol; 2009; (194):333-92. PubMed ID: 19655112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta.
    Choi YM; Jang JY; Jang M; Kim SH; Kang YK; Cho H; Chung S; Park MK
    Neuroscience; 2009 May; 160(3):587-95. PubMed ID: 19272429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the control of gastric motor activity during metamorphosis in the amphibian Xenopus laevis, with special emphasis on purinergic mechanisms.
    Sundqvist M; Holmgren S
    J Exp Biol; 2008 Apr; 211(Pt 8):1270-80. PubMed ID: 18375852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization and possible function of P2Y(4) receptors in the rodent retina.
    Ward MM; Puthussery T; Fletcher EL
    Neuroscience; 2008 Sep; 155(4):1262-74. PubMed ID: 18625291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
    Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and localization of P2 nucleotide receptor subtypes during development of the lateral ventricular choroid plexus of the rat.
    Johansson PA; Burnstock G; Dziegielewska KM; Guida E; McIntyre P; Saunders NR
    Eur J Neurosci; 2007 Jun; 25(11):3319-31. PubMed ID: 17553000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of vasopressin release by co-released neurotransmitters: mechanisms of purinergic and adrenergic synergism.
    Sladek CD; Song Z
    Prog Brain Res; 2008; 170():93-107. PubMed ID: 18655875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic receptor-mediated effects of ATP in high-grade bladder cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Jan; 101(1):106-12. PubMed ID: 17941929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain].
    Obata K; Noguchi K
    Brain Nerve; 2008 May; 60(5):483-92. PubMed ID: 18516970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct P2Y receptor subtypes regulate calcium signaling in human retinal pigment epithelial cells.
    Tovell VE; Sanderson J
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):350-7. PubMed ID: 18172112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purinergic system, microglia and neuropathic pain.
    Tsuda M; Tozaki-Saitoh H; Inoue K
    Curr Opin Pharmacol; 2012 Feb; 12(1):74-9. PubMed ID: 22036170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Jahangir A; Alam M; Carter DS; Dillon MP; Bois DJ; Ford AP; Gever JR; Lin C; Wagner PJ; Zhai Y; Zira J
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1632-5. PubMed ID: 19231178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.